have identified the causative genes within these loci. It is important to note that these analyses
18
could not identify non-polymorphic Toxoplasma genes that determine virulence. Furthermore, it
19
is currently unknown whether the identified polymorphic effectors are operative in species other 20 than laboratory mice, as will be discussed below.
22

ROP18
23
Genetic mapping of virulence in F1 progeny from a I x III cross identified a single locus 24 which encodes a rhoptry protein kinase, ROP18 [24, 25] 
7
Phosphorylation of the critical threonine residues (T102 and T108) destabilizes Irga6 by 8 preventing subunit oligomerization and GTP hydrolysis, which in turn inhibits IRG accumulation 9 on the PVM and protects the parasite from being destroyed [30] . Indeed, type I rop18 parasites
10
have reduced numbers and delayed virulence in mice compared to the type I strain, but still kill
11
100% of infected mice [28, 29] . Type II parasites failed to significantly phosphorylate these p47
12
GTPases in IFNγ activated macrophages [29] , which is surprising because ROP18 is 13 functionally expressed in this strain and type II ROP18 can confer virulence to a type III strain.
14
Thus it is likely that ROP18 works in concert with another polymorphic Toxoplasma effector (i.e.
15
inactive in type II) to destabilize IRGs at the PVM. It is important to mention that humans have 16 only two orthologous p47 GTPases, IRGC and IRGM, and both lack GAS and ISRE elements in 17 their promoters, so they are not induced by IFNγ [31] . A splice isoform of human IRGM, IRGMd,
18
localizes to the mitochondria and induces organelle fission and autophagy [32] 
13
Besides host differences, it remains to be established if there are also strain specific
14
Toxoplasma virulence factors that regulate inflammasome activation.
15
In conclusion, ending up in the wrong host could result in failure to establish chronic 16 infection due to death of the parasite, as observed in resistant animal models, including Lewis 17 rats [65] , or death to the host, as observed in C57BL/6 following type II infection, but not in 
21
American strain types IV through XIV, which should be an active avenue of future research.
22
Even less is known regarding how any of these effectors interact with the parasite's definitive between the non-canonical Toxoplasma strains and the immune system is studied.
Glossary
23
Autophagy -A cellular process by which the cell removes large damaged organelles,
24
particulates and possibly Toxoplasma containing vacuoles for degradation via the lysosome.
CD4+ T cell -T cells that recognize peptides presented on MHCI, a complex which specializes 1 in presenting peptides derived from extracellular antigens targeted to the lysosome via the 2 phagocytic pathway.
3
CD8+ T cell -T cells that recognize peptides presented on MHCI, a complex which specializes 4 in presenting peptides derived from intercellular compartments and pathogens.
5
GAS -Interferon gamma-activated sequence: promoter element.
6
GTPase -family of hydrolase enzymes that can bind and hydrolyze guanosine triphosphate 7 (GTP).
8
IKK -IκB kinase, an enzyme complex that is part of the upstream NF-B signaling cascade.
9
Inflammasome -a multiprotein oligomer responsible for the activation of pro-inflammatory 10 caspases, including caspase-1.
11
IRG -Interferon-regulated guanine triphosphatases, a family of proteins that has been 12 implicated in resistance to intracellular pathogens; sometimes called p47 GTPases to reflect 13 their molecular weight.
14 ISRE -Interferon-stimulated response element: promoter element.
15
JAK -Janus kinases, a family of intracellular non-receptor tyrosine kinases that transduce 16 cytokine-mediated signal.
17
LD 100 -dose of parasites necessary to kill 100% of infected animals.
18
LD 50 -dose of parasites necessary to kill 50% of infected animals. 
16
MAPK signaling pathways also modulate IL-12 production [94] , and there is evidence that T. 
18
Together with the ability to reduce pro-inflammatory cytokine production, type I parasites 
